logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9517232 B1

PDFFull Text
Date of Patent:
Dec. 13, 2016

Filed:

Sep. 15, 2015

Compounds for treatment of alzheimer's disease

Applicants:

Dennis Michael Godek, Glastonbury, CT (US);

Harry Ralph Howard, Bristol, CT (US);

Inventors:

Dennis Michael Godek, Glastonbury, CT (US);

Harry Ralph Howard, Bristol, CT (US);

Assignee:

Medi Synergics, LLC, Farmington, CT (US);

Attorney:
Primary Examiner:

Shengjun Wang

Int. Cl.
CPC ...
A61K 31/44 (2006.01); A61K 31/443 (2006.01); A61K 31/343 (2006.01); A61K 45/06 (2006.01); A61K 31/155 (2006.01); A61K 31/4025 (2006.01); A61K 31/404 (2006.01); A61K 31/4192 (2006.01); A61K 31/4709 (2006.01); A61K 31/4965 (2006.01); A61K 31/5377 (2006.01); A61K 31/541 (2006.01); A61K 31/55 (2006.01); C07D 405/12 (2006.01); C07D 307/78 (2006.01); C07D 307/87 (2006.01);
U.S. Cl.
CPC ...
A61K 31/443 (2013.01); A61K 31/155 (2013.01); A61K 31/343 (2013.01); A61K 31/404 (2013.01); A61K 31/4025 (2013.01); A61K 31/4192 (2013.01); A61K 31/4709 (2013.01); A61K 31/4965 (2013.01); A61K 31/5377 (2013.01); A61K 31/541 (2013.01); A61K 31/55 (2013.01); A61K 45/06 (2013.01); C07D 307/78 (2013.01); C07D 307/87 (2013.01); C07D 405/12 (2013.01);
Abstract

The invention is directed to the use of a compound of formula I, as defined herein, to a pharmaceutically acceptable salt thereof; to a pharmaceutical composition containing a compound of formula I, and to a combination of a compound of formula I with a pharmacologically effective cholinesterase inhibitor to treat a mammal, including a human, for a disorder or condition selected from the list including Alzheimer's disease, Huntington's disease, Parkinson's disease, non-Alzheimer's dementias and ALS.

Find Patent Forward Citations

Quick Actions:

Godek, Dennis. (2016). Compounds for treatment of alzheimer's disease (U.S. Patent No. 9517232). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9517232

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…